News
Popular weight loss drugs like Ozempic and Mounjaro are now linked to rare but serious cases of acute pancreatitis, including ...
Essex mother Camilla Do Rosario told her TikTok followers the one piece of advice she wishes she knew before embarking on a ...
Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market amid rising obesity and diabetes rates.
Obesity is a common risk factor for several serious health conditions like diabetes, heart disease, hypertension, fatty liver ...
More than 38 million people in the U.S. are living with diabetes.
A NEW study challenges the idea that weight loss jabs decrease muscle mass, alongside fat. Scientists say one injection – ...
CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...
Weight-loss jabs will be made available to the poorest who have the highest need, the Government has said in the NHS 10-year ...
Laura Schmidt and colleagues identify systemic financial conflicts of interest that serve as a cautionary tale for users of medical guidelines Prescribing glucagon-like peptide 1 (GLP-1) receptor ...
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results